Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534463

Cover Image

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534463

Singapore Diagnostic Labs Market, By Provider Type; By Test Type; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 2950
Unprintable PDF (Group License)
USD 3700
PDF (Enterprise License)
USD 4050

Add to Cart

Singapore Diagnostic Labs Market Size Booming to Reach USD 3.6 Billion by 2030

Singapore Diagnostic Labs Market is flourishing because of the increasing government and private sector investment in healthcare infrastructure and growing prevalence of chronic diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Singapore Diagnostic Labs Market size at USD 2.2 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Singapore Diagnostic Labs Market size to expand at a CAGR of 8.38% reaching a value of USD 3.6 billion by 2030. Rapidly aging population, a growing emphasis on early diagnosis, and increased incidences of both communicable and non-communicable illnesses as a result of changing lifestyles are major growth factors for Singapore Diagnostic Labs Market. Over the projected period, public-private investments in the development of healthcare infrastructure are also expected to propel the Diagnostic Labs Market in Singapore.

Opportunity - Increasing prevalence of chronic and communicable diseases

The rising incidence of several chronic and non-communicable illnesses in the country directly influences the growth of Singapore Diagnostic Labs Market. As per an industry estimate, there are currently over 400,000 individuals in Singapore who have diabetes, and by 2050, that figure is expected to increase to one million. According to the National Cancer Centre Institute, there were 84,002 cancer cases recorded in Singapore between 2017 and 2021, indicating a significant increase in the country's cancer incidence. Consequently, there was a surge in the country's need for preventative measures like periodic checks, which is driving up demand for diagnostic laboratories in Singapore.

Radiology Test to Grow at Fastest CAGR During 2024-2030

Singapore Diagnostic Labs Market consists of routine tests, pathology tests, and radiology tests segments on the basis of test type. The radiology segment is anticipated to register a high growth rate during the forecast period. Radiology test type is also used to diagnose and treat diseases and monitor the response of the body to the treatment. The increasing prevalence of various cancer types, such as breast cancer, and colon cancer, is propelling the demand for radiology tests in Singapore.

Impact of Escalating Geopolitical Tensions on Singapore Diagnostic Labs Market

Escalating geopolitical tensions can significantly impact the growth of Singapore Diagnostic Labs Market. Trade disruptions, such as tariffs and import restrictions, can lead to higher costs for diagnostic labs, affecting both supply and pricing. For instance, tensions between major global economies like the United States and China can create ripple effects. Heightened geopolitical tensions might divert Singapore government's focus and resources from market development initiatives toward defense and security, indirectly stalling the growth and innovations in Singapore Diagnostic Labs Market.

Competitive Landscape

Major companies in Singapore Diagnostic Labs Market include Innoquest Diagnostics Pte Ltd, Raffles Diagnostics Pte Ltd, Parkway Laboratory Services Ltd, Quest Laboratories Pte Ltd, National Healthcare Group Diagnostics, Pathology & Clinical Laboratory Pte Ltd, Reste Laboratories Pte Ltd, Biomedics Laboratory Pte Ltd, Acumen Diagnostics Pte Ltd, and Singapore Diagnostics.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Singapore Diagnostic Labs Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Singapore Diagnostic Labs Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24542

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Singapore Diagnostic Labs Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Aging Population in Singapore
      • 3.2.1.2. Technological Advancements in Medical Diagnostics
      • 3.2.1.3. Government Initiatives and Policies Aimed at Improving Healthcare Services and Promoting Early Disease Detection drive Market Growth.
      • 3.2.1.4. Increasing Prevalence of Chronic Diseases
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Advanced Diagnostics
      • 3.2.2.2. Stringent Regulatory Requirements and Lengthy Approval Processes
      • 3.2.2.3. Shortage of Skilled Healthcare Professionals
    • 3.2.3. Opportunities
      • 3.2.3.1. Innovations in Diagnostic Technologies, such as AI and Machine Learning
      • 3.2.3.2. Increasing Focus on Personalized Medicine and Tailored Treatment plans
      • 3.2.3.3. Integration of Diagnostic Services with Telemedicine Platforms
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring that Patients are Well-Informed about the Availability and Benefits of Diagnostic Tests
      • 3.2.4.2. Growing Concerns about Data Privacy and Security
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Singapore Diagnostic Labs Market: Marketing Strategies

5. Singapore Diagnostic Labs Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Provider Type
      • 5.2.1.1. Stand-Alone Diagnostic Labs
      • 5.2.1.2. Hospital-Based Diagnostic Labs
      • 5.2.1.3. Diagnostic Chains
    • 5.2.2. By Test Type
      • 5.2.2.1. Routine Tests
      • 5.2.2.2. Pathology Tests
      • 5.2.2.3. Radiology Tests
    • 5.2.3. By End User
      • 5.2.3.1. Referrals
      • 5.2.3.2. Walk-ins
      • 5.2.3.3. Corporate Clients

6. Competitive Landscape

  • 6.1. List of Key Players and Their Products
  • 6.2. Singapore Diagnostic Labs Company Market Share Analysis, 2023
  • 6.3. Competitive Benchmarking, By Operating Parameters
  • 6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

7. Impact of Escalating Geopolitical Tensions on Singapore Diagnostic Labs Market

8. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, and SWOT Analysis)

  • 8.1. Innoquest Diagnostics Pte Ltd
  • 8.2. Raffles Diagnostics Pte Ltd
  • 8.3. Parkway Laboratory Services Ltd
  • 8.4. Quest Laboratories Pte Ltd
  • 8.5. National Healthcare Group Diagnostics
  • 8.6. Pathology & Clinical Laboratory Pte Ltd
  • 8.7. Reste Laboratories Pte Ltd
  • 8.8. Biomedics Laboratory Pte Ltd
  • 8.9. Acumen Diagnostics Pte Ltd
  • 8.10. Singapore Diagnostics
  • 8.11. Other prominent players

9. Key Strategic Recommendations

10. Research Methodology

  • 10.1. Qualitative Research
    • 10.1.1. Primary & Secondary Research
  • 10.2. Quantitative Research
  • 10.3. Market Breakdown & Data Triangulation
    • 10.3.1. Secondary Research
    • 10.3.2. Primary Research
  • 10.4. Breakdown of Primary Research Respondents
  • 10.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

Product Code: BWC24542

List of Figures

  • Figure 1 Singapore Diagnostic Labs Segmentation
  • Figure 2 Singapore Diagnostic Labs Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2023
  • Figure 4 Singapore Diagnostic Labs Market Size, By Value (USD Billion), 2019-2030
  • Figure 5 Singapore Diagnostic Labs Market Share, By Provider Type, By Value (USD Billion), 2019-2030
  • Figure 6 Singapore Diagnostic Labs Market Share, By Test Type, By Value (USD Billion), 2019-2030
  • Figure 7 Singapore Diagnostic Labs Market Share, By End User, By Value (USD Billion), 2019-2030

List of Tables

  • Table 1 Singapore Diagnostic Labs Market Size, By Value (USD Billion), 2019-2030
  • Table 2 Singapore Diagnostic Labs Market Share, By Provider Type, By Value (USD Billion), 2019-2030
  • Table 3 Singapore Diagnostic Labs Market Share, By Test Type, By Value (USD Billion), 2019-2030
  • Table 4 Singapore Diagnostic Labs Market Share, By End User, By Value (USD Billion), 2019-2030
  • Table 5 Innoquest Diagnostics Pte Ltd Company Overview
  • Table 6 Innoquest Diagnostics Pte Ltd Financial Overview
  • Table 7 Raffles Diagnostics Pte Ltd Company Overview
  • Table 8 Raffles Diagnostics Pte Ltd Financial Overview
  • Table 9 Parkway Laboratory Services Ltd Company Overview
  • Table 10 Parkway Laboratory Services Ltd Financial Overview
  • Table 11 Quest Laboratories Pte Ltd Company Overview
  • Table 12 Quest Laboratories Pte Ltd Financial Overview
  • Table 13 National Healthcare Group Diagnostics Company Overview
  • Table 14 National Healthcare Group Diagnostics Financial Overview
  • Table 15 Pathology & Clinical Laboratory Pte Ltd Company Overview
  • Table 16 Pathology & Clinical Laboratory Pte Ltd Financial Overview
  • Table 17 Reste Laboratories Pte Ltd Company Overview
  • Table 18 Reste Laboratories Pte Ltd Financial Overview
  • Table 19 Biomedics Laboratory Pte Ltd Company Overview
  • Table 20 Biomedics Laboratory Pte Ltd Financial Overview
  • Table 21 Acumen Diagnostics Pte Ltd Company Overview
  • Table 22 Acumen Diagnostics Pte Ltd Financial Overview
  • Table 23 Singapore Diagnostics Company Overview
  • Table 24 Singapore Diagnostics Financial Overview
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!